These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 1977300

  • 1. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P, Broadhurst P, Raftery EB, Lahiri A.
    Am J Cardiol; 1990 Nov 01; 66(15):1118-23. PubMed ID: 1977300
    [Abstract] [Full Text] [Related]

  • 2. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P, Broadhurst P, Lahiri A.
    J Cardiovasc Pharmacol; 1991 Nov 01; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [Abstract] [Full Text] [Related]

  • 3. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P, Lahiri A.
    J Cardiovasc Pharmacol; 1992 Nov 01; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [Abstract] [Full Text] [Related]

  • 4. Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.
    DasGupta P, Lahiri A.
    Clin Investig; 1992 Nov 01; 70 Suppl 1():S98-104. PubMed ID: 1350492
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD.
    Circulation; 1995 Sep 15; 92(6):1499-506. PubMed ID: 7664433
    [Abstract] [Full Text] [Related]

  • 6. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
    Metra M, Nardi M, Giubbini R, Dei Cas L.
    J Am Coll Cardiol; 1994 Dec 15; 24(7):1678-87. PubMed ID: 7963115
    [Abstract] [Full Text] [Related]

  • 7. Vasodilating beta-blockers in heart failure.
    Raftery EB.
    Eur Heart J; 1995 Jul 15; 16 Suppl F():32-7. PubMed ID: 8521882
    [Abstract] [Full Text] [Related]

  • 8. [Tolerability and clinical effects of carvedilol in patients over 70 years of age with chronic heart failure due to left ventricular dysfunction].
    Cioffi G, Stefenelli C.
    Ital Heart J Suppl; 2001 Dec 15; 2(12):1319-29. PubMed ID: 11838355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus.
    Nodari S, Metra M, Dei Cas A, Dei Cas L.
    Eur J Heart Fail; 2003 Dec 15; 5(6):803-9. PubMed ID: 14675859
    [Abstract] [Full Text] [Related]

  • 12. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.
    Am Heart J; 2000 Apr 15; 139(4):596-608. PubMed ID: 10740140
    [Abstract] [Full Text] [Related]

  • 13. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 14. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 15. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
    Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F.
    J Am Coll Cardiol; 2000 Nov 01; 36(5):1612-8. PubMed ID: 11079666
    [Abstract] [Full Text] [Related]

  • 16. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.
    O'Keefe JH, Magalski A, Stevens TL, Bresnahan DR, Alaswad K, Krueger SK, Bateman TM.
    J Nucl Cardiol; 2000 Nov 01; 7(1):3-7. PubMed ID: 10698228
    [Abstract] [Full Text] [Related]

  • 17. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
    Buchwald A, Unterberg C, van der Does R, Wiegand V.
    Z Kardiol; 1990 Jun 01; 79(6):424-8. PubMed ID: 1974100
    [Abstract] [Full Text] [Related]

  • 18. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T, Azevedo ER, Newton GE, Parker JD, Floras JS.
    J Am Coll Cardiol; 2001 Nov 01; 38(5):1463-9. PubMed ID: 11691524
    [Abstract] [Full Text] [Related]

  • 19. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR.
    Int J Cardiol; 2001 Dec 01; 81(2-3):141-9. PubMed ID: 11744130
    [Abstract] [Full Text] [Related]

  • 20. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 01; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.